133 related articles for article (PubMed ID: 10468165)
1. Nabumetone induces less gastrointestinal mucosal changes than diclofenac retard.
Becvár R; Urbanová Z; Vlasáková V; Vítová J; Rybár I; Maldyk H; Filipowicz-Sosnowska A; Bernacka K; Mackiewicz S; Gömör B; Rojkovich B; Siro B; Bereczki J; Toth K; Sukenik S; Green L; Ehrenfeld M; Pavelka K
Clin Rheumatol; 1999; 18(4):273-8. PubMed ID: 10468165
[TBL] [Abstract][Full Text] [Related]
2. A multicenter study of nabumetone and diclofenac SR in patients with osteoarthritis.
Bellamy N; Bensen WG; Beaulieu A; Siminovitch KA; Kraag GR; Lussier A; Ahmad S; Khanna VN; Davis P; Bell MJ
J Rheumatol; 1995 May; 22(5):915-20. PubMed ID: 8587082
[TBL] [Abstract][Full Text] [Related]
3. Comparison of the upper gastrointestinal safety of Arthrotec 75 and nabumetone in osteoarthritis patients at high risk for developing nonsteroidal anti-inflammatory drug-induced gastrointestinal ulcers.
Agrawal NM; Caldwell J; Kivitz AJ; Weaver AL; Bocanegra TS; Ball J; Dhadda S; Hurley S; Hancock L
Clin Ther; 1999 Apr; 21(4):659-74. PubMed ID: 10363732
[TBL] [Abstract][Full Text] [Related]
4. Treatment of elderly patients with nabumetone or diclofenac: gastrointestinal safety profile.
Morgan GJ; Kaine J; DeLapp R; Palmer R
J Clin Gastroenterol; 2001 Apr; 32(4):310-4. PubMed ID: 11276273
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of tanezumab added on to diclofenac sustained release in patients with knee or hip osteoarthritis: a double-blind, placebo-controlled, parallel-group, multicentre phase III randomised clinical trial.
Balanescu AR; Feist E; Wolfram G; Davignon I; Smith MD; Brown MT; West CR
Ann Rheum Dis; 2014 Sep; 73(9):1665-72. PubMed ID: 23852695
[TBL] [Abstract][Full Text] [Related]
6. Influence of a specific ginger combination on gastropathy conditions in patients with osteoarthritis of the knee or hip.
Drozdov VN; Kim VA; Tkachenko EV; Varvanina GG
J Altern Complement Med; 2012 Jun; 18(6):583-8. PubMed ID: 22784345
[TBL] [Abstract][Full Text] [Related]
7. Safety experience with nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis.
Eversmeyer W; Poland M; DeLapp RE; Jensen CP
Am J Med; 1993 Aug; 95(2A):10S-18S. PubMed ID: 8356997
[TBL] [Abstract][Full Text] [Related]
8. [Comparison of the efficacy and safety of nabumetone and diclofenac sodium in the treatment of patients with rheumatoid arthritis].
Zhonghua Yi Xue Za Zhi; 2001 May; 81(9):557-60. PubMed ID: 11809123
[TBL] [Abstract][Full Text] [Related]
9. [Efficacy and safety of nabumetone in the treatment of knee osteoarthritis: a comparative clinical trial versus aceclofenac. Study Group of Nabumetone for Osteoarthritis of the Knee].
Gijón Baños J
Med Clin (Barc); 1997 Jun; 109(4):130-4. PubMed ID: 9289526
[TBL] [Abstract][Full Text] [Related]
10. A microcomputer-assisted study of nabumetone and slow release diclofenac in osteoarthritis.
Laws D; Saul S; Fehilly B
Drugs; 1990; 40 Suppl 5():29-33. PubMed ID: 2081489
[TBL] [Abstract][Full Text] [Related]
11. Safety and efficacy of nabumetone in osteoarthritis: emphasis on gastrointestinal safety.
Scott DL; Palmer RH
Aliment Pharmacol Ther; 2000 Apr; 14(4):443-52. PubMed ID: 10759624
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the efficacy and safety of oxaprozin and nabumetone in the treatment of patients with osteoarthritis of the knee.
Weaver A; Rubin B; Caldwell J; McMahon FG; Lee D; Makarowski W; Offenberg H; Sack M; Sikes D; Trapp R
Clin Ther; 1995; 17(4):735-45. PubMed ID: 8565037
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in the elderly.
Morgan GJ; Poland M; DeLapp RE
Am J Med; 1993 Aug; 95(2A):19S-27S. PubMed ID: 8356998
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the efficacy and safety of naproxen CR and nabumetone in the treatment of patients with osteoarthritis of the knee.
Cha HS; Koh JH; Jeon CH; Lee CK; Kim JS; Koh EM
Int J Clin Pharmacol Ther; 2001 Dec; 39(12):539-45. PubMed ID: 11770835
[TBL] [Abstract][Full Text] [Related]
15. Efficacy of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritis.
Lister BJ; Poland M; DeLapp RE
Am J Med; 1993 Aug; 95(2A):2S-9S. PubMed ID: 8356999
[TBL] [Abstract][Full Text] [Related]
16. A controlled study comparing the effects of nabumetone, ibuprofen, and ibuprofen plus misoprostol on the upper gastrointestinal tract mucosa.
Roth SH; Tindall EA; Jain AK; McMahon FG; April PA; Bockow BI; Cohen SB; Fleischmann RM
Arch Intern Med; 1993 Nov; 153(22):2565-71. PubMed ID: 8239849
[TBL] [Abstract][Full Text] [Related]
17. A double-masked comparison of Naprelan and nabumetone in osteoarthritis of the knee. Naprelan Study Group.
Fleischmann RM; Flint K; Constantine G; Kolecki B
Clin Ther; 1997; 19(4):642-55. PubMed ID: 9377610
[TBL] [Abstract][Full Text] [Related]
18. The efficacy, tolerability, and safety of 1200 mg/d of oxaprozin and 1500 mg/d of nabumetone in the treatment of patients with osteoarthritis of the knee.
Makarowski W; Weaver A; Rubin B; Caldwell J; McMahon FG; Noveck RJ; Lee D; Offenberg H; Sack M; Sikes D; Trapp R; Rush S; Kuss M; Ganju J; Bocanegra TS; Ratliff JM
Clin Ther; 1996; 18(1):114-24. PubMed ID: 8851458
[TBL] [Abstract][Full Text] [Related]
19. Endoscopy-controlled study of the safety of nabumetone compared with naproxen in arthritis therapy.
Roth SH
Am J Med; 1987 Oct; 83(4B):25-30. PubMed ID: 3318424
[TBL] [Abstract][Full Text] [Related]
20. Gastroduodenal tolerability of nabumetone versus naproxen in the treatment of rheumatic patients.
Bianchi Porro G; Montrone F; Petrillo M; Caruso I; Imbesi V
Am J Gastroenterol; 1995 Sep; 90(9):1485-8. PubMed ID: 7661175
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
